Results: 115 news stories
17³Ô¹ÏÍø was recently awarded a highly competitive Alzheimer’s Association research grant to investigate the gene-environment interaction and how it may contribute to an increased risk for Alzheimer’s disease. The grant will begin in April and provides $200,000 to fund the study over the next three years.
Rehabilitation Research Day combines research with lived experience
The Joe R. and Teresa Lozano Long School of Medicine at 17³Ô¹ÏÍø, in collaboration with the Be Well Institute on Substance Use and Related Disorders and its statewide program Naloxone 17³Ô¹ÏÍø, has installed a free naloxone vending machine to expand access to lifesaving opioid overdose reversal medication. Naloxone, commonly known by the […]
Lixin Song of 17³Ô¹ÏÍø’s School of Nursing is inducted into Sigma’s International Nurse Researcher Hall of Fame for her global impact in cancer and caregiving research.
For more than 20 years, Lixin Song, PhD, RN, FAAN, vice dean for research and scholarship and professor of nursing at 17³Ô¹ÏÍø (17³Ô¹ÏÍø) School of Nursing, has studied how cancer patients and their families navigate the challenging experience of making decisions about treatment while facing uncertainty, […]
The BioFest Days brought the community together April 7, for an evening of discovery and connection at the UT Health San Antonio Center for Brain Health. Hosted as part of the 12-day, citywide celebration of biomedical advancement organized by BioMed SA, the event invited attendees to explore how research, clinical care and community involvement […]
New 17³Ô¹ÏÍø study introduces analytical tool to better hone aging interventions When scientists test potential life‑extending interventions, often the central question simply asks if the intervention works. New research from 17³Ô¹ÏÍø (17³Ô¹ÏÍø) suggests that the more meaningful questions may be when does it work […]
UT Health San Antonio researchers report breakthrough findings significantly reducing symptoms for combat PTSD victims
The San Antonio Breast Cancer Symposium drew more than 11,000 attendees to downtown San Antonio and generated nearly $40 million in economic impact, according to a new report from Visit San Antonio.
UT Health San Antonio Multispecialty and Research Hospital has enrolled and treated its first clinical trial participant in a novel cancer study, marking a pivotal moment for science and patient-centered cancer care in San Antonio and South 17³Ô¹ÏÍø.
A drug once known almost exclusively for preventing organ transplant rejection is now at the center of a National Institute on Aging-funded clinical study at UT Health San Antonio, to determine how rapamycin should be used in older adults to promote healthy aging.
17³Ô¹ÏÍø (17³Ô¹ÏÍø) School of Dentistry is ranked ninth nationally and first in 17³Ô¹ÏÍø among all dental schools in the United States, according to the 2025 Blue Ridge Institute for Medical Research rankings. Based on National Institutes of Health (NIH) funding, the rankings are widely considered one of the most objective measures of biomedical […]
In its first appearance in the national standings as a united institution, 17³Ô¹ÏÍø posted a strong performance in the latest rankings from the Blue Ridge Institute for Medical Research. The Blue Ridge Institute is an independent nonprofit organization that compiles annual funding data from the National Institutes of Health.
The Sam and Ann Barshop Institute for Longevity and Aging Studies at UT Health San Antonio, will receive up to $38 million to lead a national clinical trial funded by the Advanced Research Projects Agency for Health (ARPA-H), an agency of the U.S. Department of Health and Human Services.
A large, retrospective study conducted by scientists at the University of 17³Ô¹ÏÍø at San Antonio (17³Ô¹ÏÍø) suggests that people taking glucagon-like peptide-1 (GLP-1) receptor agonists — medications that are widely prescribed for metabolic disease — have a significantly lower risk of developing colorectal cancer compared with those taking aspirin. “This is astounding to […]
A five-year, $9 million National Institutes of Health National Institute of Neurological Disorders and Stroke study that began in 2022 recently received approval at the three-year mark, allowing investigators to continue their work examining the biological mechanisms of TMJ disorders. The project is part of a national consortium of five institutions conducting complementary studies across the country.
Barshop Institute to receive up to $38 million from ARPA-H, anchoring 17³Ô¹ÏÍø as a national leader in aging and healthy longevity science
Cure Alzheimer’s Fund award aimed at better understanding microglia’s role A researcher with the Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases at UT Health San Antonio has received a two-year, $402,500 grant award from the Cure Alzheimer’s Fund to study how microglia, the brain’s resident immune cells, paradoxically might contribute to the spread of toxic forms of tau protein in […]
Chronic pain is one of the most common health conditions worldwide. Back pain is the most frequently reported type, followed closely by head and face pain linked to temporomandibular joint (TMJ) disorder. While not life-threatening like cancer or infectious disease, chronic pain can dramatically diminish quality of life and functional lifespan. As mobility declines, people […]
Ellen Kraig, PhD, professor in the Department of Cell Systems and Anatomy in the Joe R. and Teresea Lozano Long School of Medicine at the University of 17³Ô¹ÏÍø at San Antonio (17³Ô¹ÏÍø), has been named a Distinguished Fellow of the American Association of Immunologists (AAI). The AAI Distinguished Fellow designation recognizes members with […]